Global Natural Killer (NK) Cell Therapeutics Market Intelligence Report for Comprehensive Information 2018-2025

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

 Published Date : Oct-2018   |    Format :PDF   |    Number of Pages : 112
This report studies the global market size of Natural Killer (NK) Cell Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Natural Killer (NK) Cell Therapeutics in these regions.
This research report categorizes the global Natural Killer (NK) Cell Therapeutics market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Natural killer cells are a type of cytotoxic lymphocyte, which is a component of the innate immune system.
In 2017, the global Natural Killer (NK) Cell Therapeutics market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Natural Killer (NK) Cell Therapeutics market based on company, product type, application and key regions.

The various contributors involved in the value chain of Natural Killer (NK) Cell Therapeutics include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Natural Killer (NK) Cell Therapeutics include
    Chipscreen Biosciences (China)
    Affimed NV (Netherlands)
    Altor BioScience Corporation (USA)
    Innate Pharma SA (France)
    Takeda Pharmaceutical (Japan)
    Sorrento Therapeutics Inc. (USA)
    NantKwest Inc. (USA)
    Bristol-Myers Squibb (USA)
    NKT Therapeutics (USA)

Market Size Split by Type
    Mogamulizumab
    Lorvotuzumab Mertansine
    Others
Market Size Split by Application
    Cancer
    Cardiovascular Diseases
    Others

Market size split by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Natural Killer (NK) Cell Therapeutics market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
    To understand the structure of Natural Killer (NK) Cell Therapeutics market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Natural Killer (NK) Cell Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Natural Killer (NK) Cell Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Natural Killer (NK) Cell Therapeutics submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Natural Killer (NK) Cell Therapeutics are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Natural Killer (NK) Cell Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Study Coverage
    1.1  Natural Killer (NK) Cell Therapeutics Product
    1.2 Key Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by Type
        1.4.2 Mogamulizumab
        1.4.3 Lorvotuzumab Mertansine
        1.4.4 Others
    1.5 Market by Application
        1.5.1 Global Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by Application
        1.5.2 Cancer
        1.5.3 Cardiovascular Diseases
        1.5.4 Others
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Natural Killer (NK) Cell Therapeutics Market Size
        2.1.1 Global Natural Killer (NK) Cell Therapeutics Revenue 2016-2025
        2.1.2 Global Natural Killer (NK) Cell Therapeutics Sales 2016-2025
    2.2 Natural Killer (NK) Cell Therapeutics Growth Rate by Regions
        2.2.1 Global Natural Killer (NK) Cell Therapeutics Sales by Regions
        2.2.2 Global Natural Killer (NK) Cell Therapeutics Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Natural Killer (NK) Cell Therapeutics Sales by Manufacturers
        3.1.1 Natural Killer (NK) Cell Therapeutics Sales by Manufacturers
        3.1.2 Natural Killer (NK) Cell Therapeutics Sales Market Share by Manufacturers
        3.1.3 Global Natural Killer (NK) Cell Therapeutics Market Concentration Ratio (CR5 and HHI)
    3.2 Natural Killer (NK) Cell Therapeutics Revenue by Manufacturers
        3.2.1 Natural Killer (NK) Cell Therapeutics Revenue by Manufacturers (2016-2018)
        3.2.2 Natural Killer (NK) Cell Therapeutics Revenue Share by Manufacturers (2016-2018)
    3.3 Natural Killer (NK) Cell Therapeutics Price by Manufacturers
    3.4 Natural Killer (NK) Cell Therapeutics Manufacturing Base Distribution, Product Types
        3.4.1 Natural Killer (NK) Cell Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Natural Killer (NK) Cell Therapeutics Product Category
        3.4.3 Date of International Manufacturers Enter into Natural Killer (NK) Cell Therapeutics  Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
    4.1 Global Natural Killer (NK) Cell Therapeutics Sales by Type
    4.2 Global Natural Killer (NK) Cell Therapeutics Revenue by Type
    4.3 Natural Killer (NK) Cell Therapeutics Price by Type

5 Breakdown Data by Application
    5.1 Overview
    5.2 Global Natural Killer (NK) Cell Therapeutics Breakdown Data by Application

6 North America
    6.1 North America Natural Killer (NK) Cell Therapeutics by Countries
        6.1.1 North America Natural Killer (NK) Cell Therapeutics Sales by Countries
        6.1.2 North America Natural Killer (NK) Cell Therapeutics Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Natural Killer (NK) Cell Therapeutics by Type
    6.3 North America Natural Killer (NK) Cell Therapeutics by Application
    6.4 North America Natural Killer (NK) Cell Therapeutics by Company

7 Europe
    7.1 Europe Natural Killer (NK) Cell Therapeutics by Countries
        7.1.1 Europe Natural Killer (NK) Cell Therapeutics Sales by Countries
        7.1.2 Europe Natural Killer (NK) Cell Therapeutics Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Natural Killer (NK) Cell Therapeutics by Type
    7.3 Europe Natural Killer (NK) Cell Therapeutics by Application
    7.4 Europe Natural Killer (NK) Cell Therapeutics by Company

8 Asia Pacific
    8.1 Asia Pacific Natural Killer (NK) Cell Therapeutics by Countries
        8.1.1 Asia Pacific Natural Killer (NK) Cell Therapeutics Sales by Countries
        8.1.2 Asia Pacific Natural Killer (NK) Cell Therapeutics Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Natural Killer (NK) Cell Therapeutics by Type
    8.3 Asia Pacific Natural Killer (NK) Cell Therapeutics by Application
    8.4 Asia Pacific Natural Killer (NK) Cell Therapeutics by Company

9 Central & South America
    9.1 Central & South America Natural Killer (NK) Cell Therapeutics by Countries
        9.1.1 Central & South America Natural Killer (NK) Cell Therapeutics Sales by Countries
        9.1.2 Central & South America Natural Killer (NK) Cell Therapeutics Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Natural Killer (NK) Cell Therapeutics by Type
    9.3 Central & South America Natural Killer (NK) Cell Therapeutics by Application
    9.4 Central & South America Natural Killer (NK) Cell Therapeutics by Company

10 Middle East and Africa
    10.1 Middle East and Africa Natural Killer (NK) Cell Therapeutics by Countries
        10.1.1 Middle East and Africa Natural Killer (NK) Cell Therapeutics Sales by Countries
        10.1.2 Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Natural Killer (NK) Cell Therapeutics by Type
    10.3 Middle East and Africa Natural Killer (NK) Cell Therapeutics by Application
    10.4 Middle East and Africa Natural Killer (NK) Cell Therapeutics by Company

11 Company Profiles
    11.1 Chipscreen Biosciences (China)
        11.1.1 Chipscreen Biosciences (China) Company Details
        11.1.2 Company Description
        11.1.3 Sales, Revenue and Gross Margin of Natural Killer (NK) Cell Therapeutics
        11.1.4 Natural Killer (NK) Cell Therapeutics Product Description
        11.1.5 Recent Development
    11.2 Affimed NV (Netherlands)
        11.2.1 Affimed NV (Netherlands) Company Details
        11.2.2 Company Description
        11.2.3 Sales, Revenue and Gross Margin of Natural Killer (NK) Cell Therapeutics
        11.2.4 Natural Killer (NK) Cell Therapeutics Product Description
        11.2.5 Recent Development
    11.3 Altor BioScience Corporation (USA)
        11.3.1 Altor BioScience Corporation (USA) Company Details
        11.3.2 Company Description
        11.3.3 Sales, Revenue and Gross Margin of Natural Killer (NK) Cell Therapeutics
        11.3.4 Natural Killer (NK) Cell Therapeutics Product Description
        11.3.5 Recent Development
    11.4 Innate Pharma SA (France)
        11.4.1 Innate Pharma SA (France) Company Details
        11.4.2 Company Description
        11.4.3 Sales, Revenue and Gross Margin of Natural Killer (NK) Cell Therapeutics
        11.4.4 Natural Killer (NK) Cell Therapeutics Product Description
        11.4.5 Recent Development
    11.5 Takeda Pharmaceutical (Japan)
        11.5.1 Takeda Pharmaceutical (Japan) Company Details
        11.5.2 Company Description
        11.5.3 Sales, Revenue and Gross Margin of Natural Killer (NK) Cell Therapeutics
        11.5.4 Natural Killer (NK) Cell Therapeutics Product Description
        11.5.5 Recent Development
    11.6 Sorrento Therapeutics Inc. (USA)
        11.6.1 Sorrento Therapeutics Inc. (USA) Company Details
        11.6.2 Company Description
        11.6.3 Sales, Revenue and Gross Margin of Natural Killer (NK) Cell Therapeutics
        11.6.4 Natural Killer (NK) Cell Therapeutics Product Description
        11.6.5 Recent Development
    11.7 NantKwest Inc. (USA)
        11.7.1 NantKwest Inc. (USA) Company Details
        11.7.2 Company Description
        11.7.3 Sales, Revenue and Gross Margin of Natural Killer (NK) Cell Therapeutics
        11.7.4 Natural Killer (NK) Cell Therapeutics Product Description
        11.7.5 Recent Development
    11.8 Bristol-Myers Squibb (USA)
        11.8.1 Bristol-Myers Squibb (USA) Company Details
        11.8.2 Company Description
        11.8.3 Sales, Revenue and Gross Margin of Natural Killer (NK) Cell Therapeutics
        11.8.4 Natural Killer (NK) Cell Therapeutics Product Description
        11.8.5 Recent Development
    11.9 NKT Therapeutics (USA)
        11.9.1 NKT Therapeutics (USA) Company Details
        11.9.2 Company Description
        11.9.3 Sales, Revenue and Gross Margin of Natural Killer (NK) Cell Therapeutics
        11.9.4 Natural Killer (NK) Cell Therapeutics Product Description
        11.9.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    12.1 Market Opportunities and Drivers
    12.2 Market Challenges
    12.3 Market Risks/Restraints
    12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
    13.1 Value Chain Analysis
        13.1.1 Typical Suppliers of Key Natural Killer (NK) Cell Therapeutics Raw Material
        13.1.2 Natural Killer (NK) Cell Therapeutics Customers
    13.2 Sales Channels Analysis
        13.2.1 Sales Channels Analysis
        13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Author Details
    15.3 Disclaimer



List of Tables and Figures

    Figure Picture of Natural Killer (NK) Cell Therapeutics
    Figure Global Natural Killer (NK) Cell Therapeutics Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
    Figure Global Natural Killer (NK) Cell Therapeutics Production Market Share by Types (Product Category) in 2017
    Figure Mogamulizumab Product Picture
    Table Major Manufacturers of Mogamulizumab
    Figure Lorvotuzumab Mertansine Product Picture
    Table Major Manufacturers of Lorvotuzumab Mertansine
    Figure Others Product Picture
    Table Major Manufacturers of Others
    Table Global Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by Application 2018-2025 (K Units)
    Figure Cancer
    Figure Cardiovascular Diseases
    Figure Others
    Figure Natural Killer (NK) Cell Therapeutics Report Years Considered
    Figure Global Natural Killer (NK) Cell Therapeutics Market Size 2016-2025 (Million US$)
    Figure Global Natural Killer (NK) Cell Therapeutics Sales 2016-2025 (K Units)
    Table Global Natural Killer (NK) Cell Therapeutics Market Size by Regions 2016-2025 (K Units) & (Million US$)
    Table Global Natural Killer (NK) Cell Therapeutics Sales by Regions 2016-2025 (K Units)
    Table Global Natural Killer (NK) Cell Therapeutics Sales Market Share by Regions 2016-2025
    Figure Global Natural Killer (NK) Cell Therapeutics Sales Market Share by Regions 2016-2025
    Figure 2017 Global Natural Killer (NK) Cell Therapeutics Sales Market Share by Regions
    Table Global Natural Killer (NK) Cell Therapeutics Revenue by Regions 2016-2025 (Million US$)
    Table Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Regions 2016-2025
    Figure Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Regions 2016-2025
    Figure 2017 Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Regions
    Table Global Natural Killer (NK) Cell Therapeutics Sales by Manufacturers (2016-2018) (K Units)
    Table Global Natural Killer (NK) Cell Therapeutics Sales Share by Manufacturers (2016-2018)
    Figure Global Natural Killer (NK) Cell Therapeutics Sales Share by Manufacturers in 2017
    Table Natural Killer (NK) Cell Therapeutics Revenue by Manufacturers (2016-2018) (Million US$)
    Table Natural Killer (NK) Cell Therapeutics Revenue Share by Manufacturers (2016-2018)
    Figure Natural Killer (NK) Cell Therapeutics Value Share by Manufacturers in 2017
    Table Global Natural Killer (NK) Cell Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Manufacturers Natural Killer (NK) Cell Therapeutics Price (2016-2018) (USD/Unit)
    Table Natural Killer (NK) Cell Therapeutics Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Natural Killer (NK) Cell Therapeutics Product Category
    Table Date of International Manufacturers Enter into Natural Killer (NK) Cell Therapeutics Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Natural Killer (NK) Cell Therapeutics Sales by Type (2016-2025) (K Units)
    Table Global Natural Killer (NK) Cell Therapeutics Sales Share by Type (2016-2025)
    Figure Global Natural Killer (NK) Cell Therapeutics Sales Market Share by Type (2016-2025)
    Figure Global Natural Killer (NK) Cell Therapeutics Sales Market Share by Type in 2017
    Table Global Natural Killer (NK) Cell Therapeutics Revenue by Type (2016-2025) (Million US$)
    Table Global Natural Killer (NK) Cell Therapeutics Revenue Share by Type (2016-2025)
    Figure Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type (2016-2025)
    Figure Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type in 2017
    Table Natural Killer (NK) Cell Therapeutics Price by Type 2013-2018 (USD/Unit)
    Table Global Natural Killer (NK) Cell Therapeutics Sales by Application (2016-2025) (K Units)
    Table Global Natural Killer (NK) Cell Therapeutics Sales Share by Application (2016-2025)
    Figure Global Sales Natural Killer (NK) Cell Therapeutics Market Share by Application (2016-2025)
    Figure Global Sales Natural Killer (NK) Cell Therapeutics Market Share by Application (2016-2025)
    Figure North America Natural Killer (NK) Cell Therapeutics Sales Growth Rate 2016-2025 (K Units)
    Figure North America Natural Killer (NK) Cell Therapeutics Revenue Growth Rate 2016-2025 (Million US$)
    Table North America Natural Killer (NK) Cell Therapeutics Sales by Countries (2016-2025) (K Units)
    Table North America Natural Killer (NK) Cell Therapeutics Sales Market Share by Countries (2016-2025)
    Figure 2017 North America Natural Killer (NK) Cell Therapeutics Sales Market Share by Countries
    Table North America Natural Killer (NK) Cell Therapeutics Revenue by Countries (2016-2025) (Million US$)
    Table North America Natural Killer (NK) Cell Therapeutics Revenue Market Share by Countries (2016-2025)
    Figure 2017 North America Natural Killer (NK) Cell Therapeutics Revenue Market Share by Countries
    Figure United States Natural Killer (NK) Cell Therapeutics Sales Growth Rate (2016-2025) (K Units)
    Figure United States Natural Killer (NK) Cell Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure Canada Natural Killer (NK) Cell Therapeutics Sales Growth Rate (2016-2025) (K Units)
    Figure Canada Natural Killer (NK) Cell Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure Mexico Natural Killer (NK) Cell Therapeutics Sales Growth Rate (2016-2025) (K Units)
    Figure Mexico Natural Killer (NK) Cell Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Table North America Natural Killer (NK) Cell Therapeutics Sales by Type (2016-2025) (K Units)
    Table North America Natural Killer (NK) Cell Therapeutics Sales Market Share by Type (2016-2025)
    Figure 2017 North America Natural Killer (NK) Cell Therapeutics Market Share by Type
    Table North America Natural Killer (NK) Cell Therapeutics Sales by Application (2016-2025) (K Units)
    Table North America Natural Killer (NK) Cell Therapeutics Sales Market Share by Application (2016-2025)
    Figure 2017 North America Natural Killer (NK) Cell Therapeutics Market Share by Application
    Table North America Natural Killer (NK) Cell Therapeutics Sales by Company (2016-2018) (K Units)
    Table North America Natural Killer (NK) Cell Therapeutics Sales Market Share by Company (2016-2018)
    Figure North America Natural Killer (NK) Cell Therapeutics Sales Market Share by Company in 2017
    Figure Europe Natural Killer (NK) Cell Therapeutics Sales Growth Rate 2016-2025 (K Units)
    Figure Europe Natural Killer (NK) Cell Therapeutics Revenue Growth Rate 2016-2025 (Million US$)
    Table Europe Natural Killer (NK) Cell Therapeutics Sales by Countries (2016-2025) (K Units)
    Table Europe Natural Killer (NK) Cell Therapeutics Sales Market Share by Countries (2016-2025)
    Figure 2017 Europe Natural Killer (NK) Cell Therapeutics Sales Market Share by Countries
    Table Europe Natural Killer (NK) Cell Therapeutics Revenue by Countries (2016-2025) (Million US$)
    Table Europe Natural Killer (NK) Cell Therapeutics Revenue Market Share by Countries (2016-2025)
    Figure 2017 Europe Natural Killer (NK) Cell Therapeutics Revenue Market Share by Countries
    Figure Germany Natural Killer (NK) Cell Therapeutics Sales Growth Rate (2016-2025) (K Units)
    Figure Germany Natural Killer (NK) Cell Therapeutics Revenue Growth Rate (2016-2025) (K Units)
    Figure France Natural Killer (NK) Cell Therapeutics Sales Growth Rate (2016-2025) (K Units)
    Figure France Natural Killer (NK) Cell Therapeutics Revenue Growth Rate (2016-2025) (K Units)
    Figure UK Natural Killer (NK) Cell Therapeutics Sales Growth Rate (2016-2025) (K Units)
    Figure UK Natural Killer (NK) Cell Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure Italy Natural Killer (NK) Cell Therapeutics Sales Growth Rate (2016-2025) (K Units)
    Figure Italy Natural Killer (NK) Cell Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure Russia Natural Killer (NK) Cell Therapeutics Sales Growth Rate (2016-2025) (K Units)
    Figure Russia Natural Killer (NK) Cell Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Table Europe Natural Killer (NK) Cell Therapeutics Sales by Type (2016-2025) (K Units)
    Table Europe Natural Killer (NK) Cell Therapeutics Sales Market Share by Type (2016-2025)
    Figure 2017 Europe Natural Killer (NK) Cell Therapeutics Market Share by Type
    Table Europe Natural Killer (NK) Cell Therapeutics Sales by Application (2016-2025) (K Units)
    Table Europe Natural Killer (NK) Cell Therapeutics Sales Market Share by Application (2016-2025)
    Figure 2017 Europe Natural Killer (NK) Cell Therapeutics Market Share by Application
    Table Europe Natural Killer (NK) Cell Therapeutics Sales by Company (2016-2018) (K Units)
    Table Europe Natural Killer (NK) Cell Therapeutics Sales Market Share by Company (2016-2018)
    Figure Europe Natural Killer (NK) Cell Therapeutics Sales Market Share by Company in 2017
    Figure Asia Pacific Natural Killer (NK) Cell Therapeutics Sales Growth Rate 2016-2025 (K Units)
    Figure Asia Pacific Natural Killer (NK) Cell Therapeutics Revenue Growth Rate 2016-2025 (Million US$)
    Table Asia Pacific Natural Killer (NK) Cell Therapeutics Sales by Countries (2016-2025) (K Units)
    Table Asia Pacific Natural Killer (NK) Cell Therapeutics Sales Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Natural Killer (NK) Cell Therapeutics Sales Market Share by Countries
    Table Asia Pacific Natural Killer (NK) Cell Therapeutics Revenue by Countries (2016-2025) (Million US$)
    Table Asia Pacific Natural Killer (NK) Cell Therapeutics Revenue Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Natural Killer (NK) Cell Therapeutics Revenue Market Share by Countries
    Figure China Natural Killer (NK) Cell Therapeutics Sales Growth Rate (2016-2025) (K Units)
    Figure China Natural Killer (NK) Cell Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure Japan Natural Killer (NK) Cell Therapeutics Sales Growth Rate (2016-2025) (K Units)
    Figure Japan Natural Killer (NK) Cell Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure Korea Natural Killer (NK) Cell Therapeutics Sales Growth Rate (2016-2025) (K Units)
    Figure Korea Natural Killer (NK) Cell Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure India Natural Killer (NK) Cell Therapeutics Sales Growth Rate (2016-2025) (K Units)
    Figure India Natural Killer (NK) Cell Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure Australia Natural Killer (NK) Cell Therapeutics Sales Growth Rate (2016-2025) (K Units)
    Figure Australia Natural Killer (NK) Cell Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure Indonesia Natural Killer (NK) Cell Therapeutics Sales Growth Rate (2016-2025) (K Units)
    Figure Indonesia Natural Killer (NK) Cell Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure Malaysia Natural Killer (NK) Cell Therapeutics Sales Growth Rate (2016-2025) (K Units)
    Figure Malaysia Natural Killer (NK) Cell Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure Philippines Natural Killer (NK) Cell Therapeutics Sales Growth Rate (2016-2025) (K Units)
    Figure Philippines Natural Killer (NK) Cell Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure Thailand Natural Killer (NK) Cell Therapeutics Sales Growth Rate (2016-2025) (K Units)
    Figure Thailand Natural Killer (NK) Cell Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure Vietnam Natural Killer (NK) Cell Therapeutics Sales Growth Rate (2016-2025) (K Units)
    Figure Vietnam Natural Killer (NK) Cell Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure Singapore Natural Killer (NK) Cell Therapeutics Sales Growth Rate (2016-2025) (K Units)
    Figure Singapore Natural Killer (NK) Cell Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Table Asia Pacific Natural Killer (NK) Cell Therapeutics Sales by Type (2016-2025) (K Units)
    Table Asia Pacific Natural Killer (NK) Cell Therapeutics Sales Market Share by Type (2016-2025)
    Figure 2017 Asia Pacific Natural Killer (NK) Cell Therapeutics Market Share by Type
    Table Asia Pacific Natural Killer (NK) Cell Therapeutics Sales by Application (2016-2025) (K Units)
    Table Asia Pacific Natural Killer (NK) Cell Therapeutics Sales Market Share by Application (2016-2025)
    Figure 2017 Asia Pacific Natural Killer (NK) Cell Therapeutics Market Share by Application
    Table Asia Pacific Natural Killer (NK) Cell Therapeutics Sales by Company (2016-2018) (K Units)
    Table Asia Pacific Natural Killer (NK) Cell Therapeutics Sales Market Share by Company (2016-2018)
    Figure Asia Pacific Natural Killer (NK) Cell Therapeutics Sales Market Share by Company in 2017
    Figure Central & South America Natural Killer (NK) Cell Therapeutics Sales Growth Rate 2016-2025 (K Units)
    Figure Central & South America Natural Killer (NK) Cell Therapeutics Revenue Growth Rate 2016-2025 (Million US$)
    Table Central & South America Natural Killer (NK) Cell Therapeutics Sales by Countries (2016-2025) (K Units)
    Table Central & South America Natural Killer (NK) Cell Therapeutics Sales Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Natural Killer (NK) Cell Therapeutics Sales Market Share by Countries
    Table Central & South America Natural Killer (NK) Cell Therapeutics Revenue by Countries (2016-2025) (Million US$)
    Table Central & South America Natural Killer (NK) Cell Therapeutics Revenue Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Natural Killer (NK) Cell Therapeutics Revenue Market Share by Countries
    Figure Brazil Natural Killer (NK) Cell Therapeutics Sales Growth Rate (2016-2025) (K Units)
    Figure Brazil Natural Killer (NK) Cell Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure Argentina Natural Killer (NK) Cell Therapeutics Sales Growth Rate (2016-2025) (K Units)
    Figure Argentina Natural Killer (NK) Cell Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Table Central & South America Natural Killer (NK) Cell Therapeutics Sales by Type (2016-2025) (K Units)
    Table Central & South America Natural Killer (NK) Cell Therapeutics Sales Market Share by Type (2016-2025)
    Figure 2017 Central & South America Natural Killer (NK) Cell Therapeutics Market Share by Type
    Table Central & South America Natural Killer (NK) Cell Therapeutics Sales by Application (2016-2025) (K Units)
    Table Central & South America Natural Killer (NK) Cell Therapeutics Sales Market Share by Application (2016-2025)
    Figure 2017 Central & South America Natural Killer (NK) Cell Therapeutics Market Share by Application
    Table Central & South America Natural Killer (NK) Cell Therapeutics Sales by Company (2016-2018) (K Units)
    Table Central & South America Natural Killer (NK) Cell Therapeutics Sales Market Share by Company (2016-2018)
    Figure Central & South America Natural Killer (NK) Cell Therapeutics Sales Market Share by Company in 2017
    Figure Middle East and Africa Natural Killer (NK) Cell Therapeutics Sales Growth Rate 2016-2025 (K Units)
    Figure Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue Growth Rate 2016-2025 (Million US$)
    Table Middle East and Africa Natural Killer (NK) Cell Therapeutics Sales by Countries (2016-2025) (K Units)
    Table Middle East and Africa Natural Killer (NK) Cell Therapeutics Sales Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Natural Killer (NK) Cell Therapeutics Sales Market Share by Countries
    Table Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue by Countries (2016-2025) (Million US$)
    Table Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue Market Share by Countries
    Figure GCC Countries Natural Killer (NK) Cell Therapeutics Sales Growth Rate (2016-2025) (K Units)
    Figure GCC Countries Natural Killer (NK) Cell Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure Turkey Natural Killer (NK) Cell Therapeutics Sales Growth Rate (2016-2025) (K Units)
    Figure Turkey Natural Killer (NK) Cell Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure Egypt Natural Killer (NK) Cell Therapeutics Sales Growth Rate (2016-2025) (K Units)
    Figure Egypt Natural Killer (NK) Cell Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure South Africa Natural Killer (NK) Cell Therapeutics Sales Growth Rate (2016-2025) (K Units)
    Figure South Africa Natural Killer (NK) Cell Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Table Middle East and Africa Natural Killer (NK) Cell Therapeutics Sales by Type (2016-2025) (K Units)
    Table Middle East and Africa Natural Killer (NK) Cell Therapeutics Sales Market Share by Type (2016-2025)
    Figure 2017 Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Share by Type
    Table Middle East and Africa Natural Killer (NK) Cell Therapeutics Sales by Application (2016-2025) (K Units)
    Table Middle East and Africa Natural Killer (NK) Cell Therapeutics Sales Market Share by Application (2016-2025)
    Figure 2017 Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Share by Application
    Table Middle East and Africa Natural Killer (NK) Cell Therapeutics Sales by Company (2016-2018) (K Units)
    Table Middle East and Africa Natural Killer (NK) Cell Therapeutics Sales Market Share by Company (2016-2018)
    Figure Middle East and Africa Natural Killer (NK) Cell Therapeutics Sales Market Share by Company in 2017
    Table Chipscreen Biosciences (China) Company Details
    Table Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Chipscreen Biosciences (China) Recent Development
    Table Affimed NV (Netherlands) Company Details
    Table Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Affimed NV (Netherlands) Recent Development
    Table Altor BioScience Corporation (USA) Company Details
    Table Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Altor BioScience Corporation (USA) Recent Development
    Table Innate Pharma SA (France) Company Details
    Table Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Innate Pharma SA (France) Recent Development
    Table Takeda Pharmaceutical (Japan) Company Details
    Table Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Takeda Pharmaceutical (Japan) Recent Development
    Table Sorrento Therapeutics Inc. (USA) Company Details
    Table Sorrento Therapeutics Inc. (USA) Natural Killer (NK) Cell Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Sorrento Therapeutics Inc. (USA) Recent Development
    Table NantKwest Inc. (USA) Company Details
    Table NantKwest Inc. (USA) Natural Killer (NK) Cell Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table NantKwest Inc. (USA) Recent Development
    Table Bristol-Myers Squibb (USA) Company Details
    Table Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Bristol-Myers Squibb (USA) Recent Development
    Table NKT Therapeutics (USA) Company Details
    Table NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table NKT Therapeutics (USA) Recent Development
    Figure GDP by Regions / Largest Economies Pie Chart in 2016
    Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
    Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
    Figure Saving Rate Total, % of GDP, 2015
    Table Natural Killer (NK) Cell Therapeutics Value Chain
    Table Typical Suppliers of Key Natural Killer (NK) Cell Therapeutics Raw Material
    Table Natural Killer (NK) Cell Therapeutics Customers List
    Table Natural Killer (NK) Cell Therapeutics Sales Channels
    Table Natural Killer (NK) Cell Therapeutics Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Latest News

31-Oct-2018 | Medical Care

Obesity, low BMI linked to increased risk of death, study reveals

The study, published Wednesday in The Lancet Diabetes and Endocrinology and conducted by scientists at London School of Hygiene and Tropical Medicine, revealed that BMI that's either too high o ...

11-Aug-2018 | Electrical & Electronic Device

Samsung leads the pack, Smartphone Market in India Grows 29% In Third Quarter

The shipments of mobile in India are expected to reach the mark of 262 Million units till the fourth quarter arrives. Relying on the numbers, vendors dealing in mobile shipped approximately 80 Mill ...

18-Jul-2018 | Chemicals & Materials

It is Possible!! Can News Reports Be Automated?

Artificial intelligence is currently the hot topic of the town owing to its efficiency and quick work. It is a technology that is currently being used for a number of applications in the various se ...

26-Jun-2018 | Electrical & Electronic Device

Vodafone to Make Stronger Enterprise Portfolio Thus Bolstering Global Telecom Market

Vodafone India is seeking at the broadband segment to fortify its venture portfolio, said the Sunil Sood, the MD and CEO of the telecom company. The carriers had posted 2x development in the enterp ...

17-Apr-2018 | Food Service & Hospitality

Beneficiaries In Puducherry Don’t Use Subsidy To Purchase Food Grain

The Union Food Ministry has received a request from the administration of Puducherry for crediting the subsidy to the beneficiaries’ bank accounts rather than the system distributing subsidiz ...